Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT pediatric DBS validation for immunosuppressive and azole antifungal drug monitoring
NL-OMON44369Active, not recruiting
- Sponsor
- Ziekenhuisapotheek
- Start
- May 2015
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of voriconazole, fluconazole, itraconazole, posaconazole, mycophenolic acid and 4 more in Kidney allograft status (RTx), invasive mycoses and mycoses, sponsored by Ziekenhuisapotheek. Primary endpoints: Association between DBS and venous concentrations and Predictive performance of DBS for venous concentration. Started May 2015; status: active, not recruiting.
02
Drugs
voriconazolefluconazoleitraconazoleposaconazolemycophenolic acid
03
Conditions
Kidney allograft status (RTx)invasive mycosesmycoses
Beyond the preview
Go deeper on NL-OMON44369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44369.